Nautilus Launches "NicoFix" - The World's First Smoking-Cessation Coffee

Stuttgart, Germany - Nautilus GmbH Laboratoriumsbedarf & Co. KG, a pioneer in innovative products in pharmaceuticals, chemicals, and life science research, proudly unveils its latest groundbreaking creation: NicoFix, the world's first smoking-cessation coffee.

NicoFix is a patent-pending, nicotine-infused coffee designed for smokers seeking an alternative to traditional smoking methods. Richard H. Davis, President and CEO of Nautilus GmbH Laboratoriumsbedarf & Co. KG and the visionary behind NicoFix, describes it as a revolutionary solution for those who desire a true 'Nicotine Fix' without the harmful effects of smoking.

Unlike conventional coffee, NicoFix contains a carefully measured shot of natural nicotine, equivalent to the nicotine content found in a couple of regular filtered cigarettes. Davis emphasizes, "NicoFix coffee is not your average cup of joe. It is marketed to smokers who want to satisfy their cigarette cravings without lighting up, providing an alternative to cigarettes, cigars, cigarillos, chewing tobacco, and snus."

NicoFix coffee, targeted at the average smoker in need of a quick pick-me-up, contains 3 milligrams of naturally derived nicotine alkaloids per cup. While NicoFix can help alleviate cravings, it is not positioned as a 'cure' for smoking; rather, it offers a bridge for individuals looking to make lifestyle changes without succumbing to sudden withdrawal symptoms.

"The worldwide awareness about the harmful effects of cigarette smoking will offer immense growth opportunities for NicoFix coffee," states Davis, reflecting on the potential impact of this innovative product.

In a strategic move, Starbucks is set to embrace this revolutionary concept. Starbucks plans to incorporate coffee beans containing nicotine, recently developed in South America under U.S. Patent Number 6749882-B2: Coffee Drink Comprising Pre-Extracted Nicotine.

Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Photo Caption: CNBC's Jane Wells enjoying a Starbucks' Cooofffffeeeeee. Photo URL: https://twitpic.com/33e7ez

For media inquiries, please contact:

Richard H. Davis
President and CEO
Nautilus GmbH Laboratoriumsbedarf & Co. KG
Stuttgarter Str., 70469 Stuttgart, Germany
Email: news@nicofix.eml.monster
‪Mobiltelefon: (619) 932-1956‬
http://tinyurl.com/NicoFixKaffee
https://www.youtube.com/watch?v=z_3QCVg-heA&t=35s
https://twitter.com/NicoShot

About Nautilus GmbH Laboratoriumsbedarf & Co. KG:

Nautilus GmbH Laboratoriumsbedarf & Co. KG is a German-based company with over 32 years of expertise in developing and producing innovative products in the pharmaceuticals, chemicals, and life science research sectors. Renowned for delivering high-quality products and services, the company continues to lead the way in scientific advancements.

This release was published on openPR.